普莱柯：获得一款新兽药注册证书

Core Viewpoint - The company, Pulaike (603566), has received approval from the Ministry of Agriculture and Rural Affairs for a new veterinary drug, a four-in-one inactivated vaccine for poultry diseases, marking a significant development in the veterinary pharmaceutical industry [1] Group 1: Company Developments - Pulaike and its wholly-owned subsidiary, Luoyang Huizhong Biotechnology Co., Ltd., jointly applied for the new veterinary drug, which includes vaccines for Newcastle disease, infectious bronchitis, avian influenza (H9 subtype), and avian adenovirus disease [1] - The new veterinary drug registration certificate was publicly announced on October 11, indicating successful regulatory approval [1] Group 2: Market Context - As of now, there are no similar four-in-one inactivated vaccine products available for sale in the poultry market, highlighting a potential competitive advantage for the company [1]